In this context, DNAJC13 is seen as a potential therapeutic target, whereas the situation is reversed in stomach cancer; the enriched gene sets for the DNAJC13low phenotype primarily included cell redox homeostasis and those involved in mitochondrial complexes and metabolism. Here, DNAJC13 is linked to gastric cancer.